report revenu ep came light expect howev adjust unplan
fx compens cost organ revenu well ahead ep line
core revenu ep guidanc rais intrigu improv
growth profil remain sidelin due valuat note consensu
estim need come fx divestitur
revenu report light consensu report
revenu estim light forecast howev report miss
entir driven unfavor fx organ revenu growth
consensu expect rel consensu estim busi sub-
segment da y/i organ diagnost
organ note fx greater unfavor impact
gross margin y/i expect note
unfavor fx mix da segment revenu expect segment
lower margin corpor averag neg impact gross margin oper
margin y/i expect howev increment
fx headwind unplan compens expens neg impact margin
exclud item margin still expect believ
mostli attribut unfavor busi mix ep y/i
consensu forecast howev increment fx headwind
unplan compens expens neg impact ep favor tax
benefit ep net item ep line consensu
estim
report revenu guidanc updat bridg fx
organ organ revenu growth guidanc increas
full year ep expect approxim decreas bridg
compens fx core tax revenu guid
consensu head print delta larg due fx small
product line divestitur ep guid prior
expect differ primarili attribut fx note origin
guidanc year unlik unachiev due increment work capit
complet acquisit increas invest new product appear
bear fruit compani increas organ revenu growth guidanc third
consecut quarter addit see clear path organ revenu growth
beyond even factor difficult comparison manag clearli
deserv credit accomplish note share still close ytd
continu page
pleas see page report import disclosur
past year increas invest made sever portfolio chang
divestitur acquisit launch number new product action
appear bear fruit believ risk/reward get interest confid
build outlook msd core revenu growth growth euroimmun
p-t base ep
ep trend slightli ahead expect
revenu growth acceler
beyond
deploy strategi ep
balanc invest growth area
hsd
deploy strategi ep
ou growth demonstr potenti
revenu growth limit
margin improv come short
provid divers array product servic address
diagnost research environment industri laboratori servic market report
two busi segment discoveri analyt solut diagnost
howev share trade premium ev/ebitda
price-to-earnings basi respect believ improv growth outlook somewhat reflect
stock valuat addit note consensu ep estim like
high due fx recent product line divestitur accordingli
await attract entri point price target ep
premium peer group
compani report thomson eikon cowen compani
cowen vs consensu mm except core neglig fx oper margin y/i bridg fx tax core revenu metric mm except analyt currenc growth growth currenc growth organ growth statement mm except per count forecast sg forecast oper margin y/i expect howev increment fx headwind unplan compens expens neg impact margin exclud item margin still expect believ mostli attribut unfavor mix higher expect da revenu lower expect tax rate benefit ep y/i consensu forecast howev increment fx headwind unplan compens expens neg impact ep favor tax benefit ep net item ep line consensu estim consensu increas da revenu forecast da revenu beat consensu estim organ revenu growth forecast streetaccount consensu increas diagnost organ revenu growth estim diagnost revenu consensu estim organ revenu growth line forecast streetaccount consensu organ revenu report light consensu report revenu estim light forecast howev report miss entir driven unfavor fx organ revenu growth expect rel consensu estim busi sub-seg da y/i organ diagnost organ note fx greater unfavor impact diagnost segment gross margin y/i expect note unfavor fx mix better expect da perform lower margin dx segment neg impact gross cowen
compani report cowen compani
mm except yr organ account organ fx ei growth currenc organ exchang analyt organicpurchas account growth note food businessconst currenc note onesourc businessorgan organ total exchang organicpurchas account dx organ growth tradit organ growth currenc organ core growth exclud ei ei add core growth total ei grow y/i exchang cowen
compani report thomson eikon cowen compani
mm except yr cagrcommentsnet organ organ fx ei expect increas revenu gener sg expect increas revenu oper oper margin bridg fx unplan compens non-oper interest net interest expense/oth similar tax rate per share bridg compens fx organ taxshar consensu except gross op cowen
price target base sever methodolog may includ analysi market risk
group ev/ebitda premium discount averag group price-to-earnings sum part net asset
valu dividend return return equiti roe next month
risk medic life scienc tool sector may includ reduct delay research
develop budget govern fund reduc delay purchas
health care hospit custom increas extend regulatori hurdl process
regul product increas depend volatil emerg market revenu
profit gener macroeconom challeng
make invest recommend earli stage pre-commerci ls dt
compani base upon assess technolog probabl market success
competit regulatori reimburs etc potenti market opportun
event success howev compani lack tradit and/or matur
financi metric believ good methodolog assign specif
target price stock
downsid risk includ limit macroeconom deterior
current level inabl execut integr eros market share price
due competit inabl deliv incremental/decrement margin target
value-destruct upsid risk includ limit better expect
revenue/ep disciplin buyer seller improv
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock thermo fisher scientif secur
cowen compani llc manag co-manag public offer past month
cowen compani llc receiv compens invest bank servic past month
past month client cowen compani llc cowen compani llc provid provid invest bank servic
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
inform herein base sourc believ reliabl guarante us purport complet statement summari avail data
opinion express herein statement judgment date subject chang without notic opinion recommend herein take
account individu client circumst object need intend recommend invest strategi recipi report must make
independ decis regard secur subject research report case secur financi instrument may difficult valu sell reliabl
inform valu risk relat secur financi instrument may difficult obtain extent report discuss legal proceed issu
prepar express intend express legal conclus opinion advic salespeopl trader profession may provid oral written
market commentari trade strategi client reflect opinion contrari opinion express research princip trade area invest
busi may make invest decis inconsist recommend view express research cowen compani llc maintain physic electron
procedur inform barrier address flow inform among depart within cowen compani llc order prevent avoid conflict
interest respect analyst recommend
import disclosur regard compani subject research report pleas contact complianc depart cowen compani llc lexington
avenu floor new york ny addit import disclosur except valuat method risk avail firm disclosur
websit http //cowen bluematrix com/sellside/disclosur action
equiti research price target cowen compani llc assign price target compani cover equiti research unless note otherwis equiti research price target
issuer stock repres valu analyst reason expect stock reach perform period twelv month price target equiti secur
report consid context prior publish cowen compani llc equiti research report includ disclosur equiti report
firm disclosur websit may may includ equiti research price target well develop relat issuer industri financi market
equiti research price target valuat methodolog risk associ achiev given equiti research price target pleas see analyst equiti research report
publish target
cowen credit research trade due natur fix incom market issuer debt secur issuer discuss cowen credit research trade
research report assign rate price target may continu follow accordingli investor must regard brand report provid stand-alon
analysi reflect analyst opinion date report expect continu analysi addit report relat issuer debt secur
time time cowen credit research trade research analyst provid invest recommend secur subject report
recommend intend time date public within paramet specifi individu report cowen credit research trade
invest recommend made strictli case-by-cas basi recommend provid part overarch rate system set consist
appli benchmark view express report may differ view offer firm equiti research report prepar client
notic uk investor public produc cowen compani llc regul unit state finra commun person kind
describ articl servic market act promot order must transmit person without
notic european union investor individu produc recommend requir obtain certain licens financi regulatori author finra review
author current licens statu histori employ histori report regulatori custom disput crimin matter via brokercheck finra http //
brokercheck finra org/ individu licens statu finra constru endors finra gener biograph inform also avail
research analyst www cowen com
addit complet preced recommend histori relat recommend research report avail http //cowen bluematrix com/sellside/
recommend contain report produc octob et dissemin novemb et
copyright user agreement gener inform relat report
cowen compani llc right reserv member nyse finra sipc research report prepar exclus use cowen client may
reproduc display modifi distribut transmit disclos whole part form manner other outsid organ without express prior
written consent cowen cowen research report distribut simultan client elig receiv research report unauthor use disclosur
